- Carson-based Company, Moleaer, Deploys Patented Nanobubble Generators to Eliminate Source of Foul Odor at Dominguez Channel
- Teva temporarily padlocks a plant after FDA cites it for contamination
- #JPM22: Catalent CEO John Chiminski with John Carroll — Our predictions for the biopharma industry in 2022
- AstraZeneca’s MCL-1 cancer drug put on hold after flagging a safety issue — 2 years after Amgen axed rival drug
- STAT+: Amgen, Arrakis Therapeutics partner to develop oral drugs that eliminate troublesome RNA
- The U.S. is more racially diverse than ever. Will people of color unify politically?
- Largest Catalent site will expand cold chain offerings; First phase completed for Avid’s CA upgrade
- JPM22, Day 2: Freenome passes $1B funding mark; Amgen spices things up with Arrakis
- Anivive Licenses Novel Canine Cancer Therapeutic to Expand Sales and Accelerate Pipeline
- UCLA WEBINAR (Jan. 13) Facts, Myths, and Misinformation on COVID-19 – Protecting Black/Latinx Families
Copyright © 2021 Biotech Networks, LLC
